Phase 1 Study of DS-6051b in Japanese Subjects With Advanced Solid Malignant Tumors

NCT02675491 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Malignant Tumors

Interventions

DRUG: DS-6051b

Sponsor

Daiichi Sankyo Co., Ltd.